• 1
    Yazdany J, Schmajuk G, Robbins M, Daikh D, Beall A, Yelin E, et al.Choosing wisely: the American College of Rheumatology's top 5 list of things physicians and patients should question.Arthritis Care Res (Hoboken)2013;65:32939.
  • 2
    Singh JA, Furst DE, Bharat A, Curtis JR, Kavanaugh AF, Kremer JM, et al.2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis.Arthritis Care Res (Hoboken)2012;64:62539.
  • 3
    Furst DE, Koehnke R, Burmeister LF, Kohler J, Cargill I.Increasing methotrexate effect with increasing dose in the treatment of resistant rheumatoid arthritis.J Rheumatol1989;16:31320.
  • 4
    Braun J, Kastner P, Flaxenberg P, Wahrisch J, Hanke P, Demary W, et al, for the MC-MTX.6/RH Study Group.Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: results of a six-month, multicenter, randomized, double-blind, controlled, phase IV trial.Arthritis Rheum2008;58:7381.